368866-32-4

Basic information

• Product Name: (S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER
• Synonyms: (S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER;(S)-methyl 2-amino-2-(tetrahydro-2H-pyran-4-yl)acetate;L-4'-Tetrahydropyranylglycinemethyl ester;REF DUPL: L-4'-Tetrahydropyranylglycinemethyl ester;2H-Pyran-4-acetic acid, .alpha.-aminotetrahydro-, methyl ester, (.alpha.S)-;Methyl 2-aMino-2-(tetrahydro-2H-pyran-4-yl)acetate;A82211;methyl(2S)-2-amino-2-(oxan-4-yl)acetate
• CAS NO: 368866-32-4
• Molecular Formula: C8H15NO3
• Molecular Weight: 173.21
• Mol File: 368866-32-4.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 244.1 °C at 760 mmHg
• Flash Point: 94.5 °C
• Appearance: /
• Density: 1.104 g/cm³
• Vapor Pressure: 0.0309mmHg at 25°C
• Refractive Index: 1.471
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: (S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER(368866-32-4)
• EPA Substance Registry System: (S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER(368866-32-4)

Safety Data

• Hazardous Substances Data: 368866-32-4(Hazardous Substances Data)

Usage

General Description

(S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER is a chemical compound with a complex molecular structure. It consists of a tetrahydro-pyran-4-yl moiety, an amino group, a methyl ester group, and an acetic acid unit. (S)-AMINO-(TETRAHYDRO-PYRAN-4-YL)-ACETIC ACID METHYL ESTER is commonly used in organic synthesis and medicinal chemistry as a building block for the preparation of various pharmaceuticals and biologically active molecules. Its unique structure and reactivity make it a valuable intermediate in the production of drugs and other fine chemicals. Additionally, its chiral nature allows for the preparation of enantiopure compounds, which are often necessary in pharmaceutical research and development.

InChI:InChI=1/C8H15NO3/c1-11-8(10)7(9)6-2-4-12-5-3-6/h6-7H,2-5,9H2,1H3/t7-/m0/s1

Upstream product

• 894789-28-7 (S)-N-Cbz-pyranyl glycine methyl ester 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 477584-90-0 methyl 2-(((benzyloxy)carbonyl)amino)-2-(dihydro-2H-pyran-4(3H)-ylidene)acetate 
• 477585-43-6 methyl 2-amino-2-(tetrahydro-2H-pyran-4-yl)acetate 
• 950192-18-4 racemic Cbz-pyranylglycine methyl ester 

Downstream Products

• 1009120-03-9 (S)-methoxycarbonylamino(tetrahydropyran-4-yl)acetic acid 
• 1035278-84-2 C₂₈H₃₅N₅O₃ 
• 1035279-38-9 C₃₃H₄₃N₅O₅ 

Relevant articles and documents

FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

no abstract published

SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, D and R2 are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.

TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION

Tetracyclic heterocycle compounds of formula (I) and pharmaceutically acceptable salts thereof are provided, wherein A, A', G, R1, R15, U, V, V', W, W, X, X', Y and Y' are as defined in the invention. The pharmaceutical compositions comprising these compounds and the use of the compounds for treating hepatitis C virus (HCV) infection are also provided.